Krystal Biotech buy Chardan Capital
Start price
22.08.25
/
50%
€127.05
Target price
22.08.26
€186.08
Performance (%)
76.54%
Price
15:15
€224.30
Summary
This prediction is currently active. With a performance of 76.54% the BUY prediction by Chardan_Capital is a big success. This prediction currently runs until 22.08.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 0.139% | 0.139% |
| iShares Core DAX® | 0,75 % | -8,50 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % |
| iShares S&P 500 | -0,59 % | -2,87 % |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) had its price target lowered by analysts at Chardan Capital from $219.00 to $216.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Chardan_Capital for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€172.25
20.02.25
20.02.25
€208.60
20.02.26
20.02.26
27.14%
21.02.26
21.02.26
Krystal Biotech
Start price
Target price
Perf. (%)
€151.90
18.12.24
18.12.24
€202.14
18.12.25
18.12.25
30.09%
19.12.25
19.12.25
Krystal Biotech
Start price
Target price
Perf. (%)
€165.85
12.12.24
12.12.24
€201.99
12.12.25
12.12.25
25.47%
13.12.25
13.12.25